Biofrontera Q3 EPS $(0.42) Misses $(0.11) Estimate, Sales $9.100M Beat $8.500M Estimate
Benzinga Newsdesk 15 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.11) by 281.82 percent. This is a 32.26 percent increase over losses of $(0.62) per share from
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.11) by 281.82 percent. This is a 32.26 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $9.100 million which beat the analyst consensus estimate of $8.500 million by 7.06 percent. This is a 30.22 percent increase over sales of $6.988 million the same period last year.